Dr. Scott Rocklage became the managing partner at 5 AM Ventures in the year 2004. He initially joined 5 AM Ventures as a partner in the year 2003. He has more than 30 years’ experience in healthcare management in conjunction with a scientific background that has played a significant role in strengthening his foundation. His leadership was a critical contribution that led achievement of FDA (Federal Drug Administration) confirmation for Omniscan, Cubicin, and Teslascan. These were brand-new drug applications then. The 5 AM ventures run offices in California, San Francisco, and Waltham. Rocklage is based in Waltham.
Before joining the 5 AM Ventures, Rocklage was the Chairman and the CEO of Cubist Pharmaceuticals. He was also the president and the CEO of Nycomed Salutar. He ran many research and designs positions when he was serving Catalytica and Salutar. Also, he served as the president as well as the CEO of Amersham Health, Co-President and Executive Chairman of Ilypsa. The other positions that he had served incorporate Inc. and Chairman of Novra Therapeutics, Chairman of the Board at Cidara Therapeutics. His experience I Strategic leadership, science, and healthcare has been well rooted by his background. As a result, he became a highly effective and efficient leader as well as a strategist in venture capital, pharmaceutics as well as healthcare fields.
He had a profound academic background. He acquired a Bachelor of Science degree in Chemistry at the University of California which is located in Berkeley. He then pursued a Ph.D. of the same in Massachusetts Institute of Technology. As he was pursuing his Ph.D., he used to carry research in Richard R. Schrock laboratory. In 2005, Richard R. Schrock was Nobel Prize winner in chemistry. He is also an inventor as well as a co-inventor of more than 30 United States patents. Rocklage was also an author of over 100 publication on per review.
It’s through the visionary leadership of Dr. Scott Rocklage that 5 AM Ventures has been rated among venture capital company’s set towards the development of life science companies regarding the future generation. Dr. Scott Rocklage is the key driver in the investment and healthcare sector. All credit goes to him for his great achievement in the healthcare departments. Learn more: https://www.bloomberg.com/research/stocks/private/person.asp?personId=216045&privcapId=3200727